Higher rates of upper respiratory tract infection in adults, particularly health care workers, were not associated with prior COVID-19 infection and were more likely attributable to other ...

In nonhospitalized patients, treatment of acute COVID-19 with nirmatrelvir-ritonavir reduced long COVID risk in older vs younger adults, supporting its use in high-risk patients to prevent both acute ...

Among ICU patients with cirrhosis and sepsis, a high lactate-to-hematocrit ratio predicted short- and long-term mortality.

Asthma clinical remission among patients taking dupilumab is most likely to occur in those with increased baseline BEC and FeNO levels.

Credit: Getty Images Researchers compared OSA patients with obesity treated with tirzepatide vs placebo to determine differences in AHI rates through post-hoc analyses of 2 phase 3 trials. Patients ...

Credit: Getty Images Researchers assessed COVID-19 respiratory failure severity outcomes in adults treated with paridiprubart, an mAb inhibiting TLR4, the receptor implicated in ARDS. Among ICU ...

CHEST 2025, the 90th annual meeting of the American College of Chest Physicians, opens on "Love Your Lungs Day" on October 19 in Chicago.

CHIP at a VAF of 10% or greater is the strongest predictor of whether daily low-dose aspirin can help prevent cancer in healthy, older adults.

Smoking among individuals with cirrhosis exacerbates inflammation, fibrogenesis, and angiogenesis, and increases risk for extrahepatic cancers in ACLD.

Early metformin initiation after COVID-19 infection is associated with a substantially lower 1-year risk for long COVID in adults with overweight or obesity, according to study results published in ...

Investigators assessed markers of chronic kidney disease (CKD) with cancer risks using data from more than one million patients.

The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.